COST-UTILITY ANALYSIS COMPARING A TWO-DOSE TO A THREE-DOSE HUMAN PAPILLOMAVIRUS VACCINE FOR WOMEN IN THE UNITED STATES
May 1, 2016, 00:00 AM
10.1016/j.jval.2016.03.1231
https://www.valueinhealthjournal.com/article/S1098-3015(16)01299-7/fulltext
Section Title :
Infection - Cost Studies
Section Order :
737
First Page :
A219
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01299-7&doi=10.1016/j.jval.2016.03.1231